{"disease":{"id":"coronavirus-disease-covid-19","name":"coronavirus disease covid 19"},"drugs":{"marketed":[{"drug_id":"tocilizumab","indication_name":"Coronavirus Disease 2019 (COVID-19)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Roactemra","generic_name":"tocilizumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"Interleukin-6 receptor","drug_class":"Interleukin-6 Receptor Antagonist [EPC]","quality_score":10,"revenue":null,"mechanism":"Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04941144","title":"Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination","phase":"","overall_status":"COMPLETED","enrollment_count":8538,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT04327206","title":"BCG Vaccination to Protect Healthcare Workers Against COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":6828,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":false},{"nct_id":"NCT04375761","title":"COVID-19: Human Epidemiology and Response to SARS-CoV-2","phase":"","overall_status":"COMPLETED","enrollment_count":5599,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04545047","title":"Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":5044,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT05594147","title":"An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib","phase":"","overall_status":"COMPLETED","enrollment_count":4103,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04348214","title":"Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals","phase":"","overall_status":"COMPLETED","enrollment_count":4040,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT05722665","title":"Convolutional Neural Network Model to Detect Coronavirus Disease 2019 (COVID-19) Pneumonia in Chest Radiographs","phase":"","overall_status":"COMPLETED","enrollment_count":3599,"lead_sponsor_name":"Fundacion Clinica Valle del Lili","has_results":false},{"nct_id":"NCT06667700","title":"A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":3082,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT05534074","title":"University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"University Hospital, Ioannina","has_results":false},{"nct_id":"NCT04939428","title":"Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2441,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04443712","title":"Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19)","phase":"","overall_status":"UNKNOWN","enrollment_count":1900,"lead_sponsor_name":"Samia Girgis","has_results":false},{"nct_id":"NCT04575597","title":"Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":1735,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04508023","title":"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1284,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT04378777","title":"Immunophenotyping Assessment in a COVID-19 Cohort","phase":"","overall_status":"COMPLETED","enrollment_count":1227,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT07089680","title":"A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT04558307","title":"Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04350931","title":"Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":900,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT04394117","title":"Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":787,"lead_sponsor_name":"The George Institute","has_results":false},{"nct_id":"NCT05364671","title":"Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":771,"lead_sponsor_name":"Materia Medica Holding","has_results":true},{"nct_id":"NCT05492227","title":"SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study","phase":"","overall_status":"COMPLETED","enrollment_count":607,"lead_sponsor_name":"TransGen Biotech Co., LTD","has_results":false},{"nct_id":"NCT04659356","title":"NOSOcomial COVID-19 in ICU (NOSOCOVID)","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT06189040","title":"Immunogenicity After COVID-19 Vaccines in Adapted Schedules","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":580,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT04286503","title":"The Clinical Study of Carrimycin on Treatment Patients With COVID-19","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":520,"lead_sponsor_name":"Beijing YouAn Hospital","has_results":false},{"nct_id":"NCT05364268","title":"Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation","phase":"","overall_status":"COMPLETED","enrollment_count":514,"lead_sponsor_name":"AudibleHealth AI, Inc.","has_results":false},{"nct_id":"NCT04346056","title":"Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT04575584","title":"Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":304,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05007080","title":"A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":304,"lead_sponsor_name":"Janssen Vaccines & Prevention B.V.","has_results":true},{"nct_id":"NCT04355351","title":"Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)","phase":"NA","overall_status":"COMPLETED","enrollment_count":303,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT04403932","title":"Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Hospital San Carlos, Madrid","has_results":false},{"nct_id":"NCT04898166","title":"Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Syeda Mahanum Ali","has_results":true},{"nct_id":"NCT05184062","title":"A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":272,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04498247","title":"A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":263,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05375760","title":"A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":251,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04369989","title":"Observational Study of COVID-19 Treatment Efficacy","phase":"","overall_status":"TERMINATED","enrollment_count":250,"lead_sponsor_name":"OSF Healthcare System","has_results":false},{"nct_id":"NCT04588363","title":"COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C","phase":"","overall_status":"COMPLETED","enrollment_count":244,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04317040","title":"Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":234,"lead_sponsor_name":"Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT04569786","title":"Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":232,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04742725","title":"A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":231,"lead_sponsor_name":"Prothione, LLC","has_results":false},{"nct_id":"NCT04894409","title":"Evaluation of Silver Nanoparticles for the Prevention of COVID-19","phase":"NA","overall_status":"COMPLETED","enrollment_count":231,"lead_sponsor_name":"Cluster de Bioeconomia de Baja California, A.C","has_results":false},{"nct_id":"NCT04380961","title":"A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":212,"lead_sponsor_name":"Janssen Pharmaceutica N.V., Belgium","has_results":true},{"nct_id":"NCT04677660","title":"A Study of TAK-919 in Healthy Japanese Adults (COVID-19)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT06305793","title":"RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Kanecia Obie Zimmerman","has_results":false},{"nct_id":"NCT04583982","title":"ImmuneSense™ COVID-19 Study","phase":"","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Adaptive Biotechnologies","has_results":false},{"nct_id":"NCT04572360","title":"Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":172,"lead_sponsor_name":"Hong Kong Baptist University","has_results":false},{"nct_id":"NCT05119855","title":"Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":165,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04344977","title":"Collection of Anti-SARS-CoV-2 Immune Plasma","phase":"","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05299359","title":"A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04341116","title":"Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"I-Mab Biopharma US Limited","has_results":true},{"nct_id":"NCT04473170","title":"Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"Abu Dhabi Stem Cells Center","has_results":false},{"nct_id":"NCT05514691","title":"Evaluation of Clinical Performance and Usability of iStatis COVID-19 Ag Rapid Test at POC","phase":"NA","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"bioLytical Laboratories","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}